Age-related Macular Degeneration (AMD)
Age-related Macular Degeneration (AMD)
Age-related Macular Degeneration (AMD) is a slow, age-related deterioration of the macula — the part of the retina responsible for sharp central vision. It is the leading cause of central vision loss after the age of 60. AMD does not cause complete blindness — the side (peripheral) vision is preserved — but it makes reading, recognising faces, driving and detailed work difficult.
The Two Types of AMD
AMD comes in two main forms, both starting from the same underlying ageing changes:
- Dry AMD — the more common form (about 85% of cases). The macula slowly thins and accumulates deposits called drusen. Vision loss is gradual.
- Wet AMD — less common (about 15% of cases) but causes most of the severe vision loss. Abnormal new blood vessels grow under the retina, leak fluid or blood, and rapidly damage the macula.
About 10–15% of patients with dry AMD will eventually develop wet AMD in one or both eyes. That is why anyone with dry AMD needs regular monitoring.
Symptoms
Early AMD
- Often no symptoms at all — the diagnosis is made on routine eye exam
- Mild blurring or difficulty reading small print
- Slightly slower adaptation when moving from bright light to dim light
Advanced dry AMD (geographic atrophy)
- A central blurred or dark area that gradually expands
- Faces become harder to recognise
- Reading becomes slow and tiring
Wet AMD
- Sudden distortion of straight lines
- A new dark spot or smudge in the centre of vision
- Sudden drop in central vision over days or weeks
- Difficulty reading or doing fine work that was easy a week before
Who Is at Risk?
- Age over 60 — the strongest risk factor
- Family history of AMD
- Smoking — doubles the risk; the most important modifiable factor
- High blood pressure and cardiovascular disease
- Long-term UV exposure without protection
- Poor diet, obesity, low intake of green leafy vegetables and fish
- Light iris colour (in some populations)
How We Diagnose AMD
- Dilated retinal examination — the first step; drusen, pigment changes and bleeds are usually visible
- OCT — the most important test. Shows drusen, fluid, atrophy and bleeds in cross-section
- OCT-Angiography — detects abnormal new vessels (CNV) without any dye injection
- Fundus autofluorescence (FAF) — maps areas of retinal cell loss
- Fluorescein angiography and ICG angiography — for difficult cases, especially when ruling out polypoidal disease (PCV)
- Amsler grid — for self-monitoring at home
Treatment
For Dry AMD
There is no medicine that fully cures dry AMD, but several steps slow the disease meaningfully:
- AREDS2 vitamins — a specific combination of antioxidants, lutein, zeaxanthin and zinc reduces the risk of progression to advanced AMD by about 25% in eligible patients.
- Diet rich in green leafy vegetables, fish, nuts and fruit.
- Quit smoking completely.
- Blood pressure and cardiovascular health.
- UV protection — sunglasses and a hat outdoors.
- Amsler grid weekly to catch conversion to wet AMD early.
- Newer therapies for geographic atrophy (complement inhibitors) are emerging — we will advise if you are a candidate.
For Wet AMD
- Intravitreal anti-VEGF injections — the cornerstone of wet AMD treatment. Drugs used include Ranibizumab, Aflibercept, Brolucizumab, Faricimab and Bevacizumab. The standard plan is three monthly loading injections, then maintenance based on OCT response.
- Photodynamic Therapy (PDT) — mainly for polypoidal lesions; sometimes combined with anti-VEGF.
- Submacular surgery — rarely needed, for very large submacular bleeds.
| Dry AMD | Wet AMD | |
|---|---|---|
| Frequency | About 85% of cases | About 15% of cases |
| How it develops | Slow (years) | Often rapid (days–weeks) |
| Main finding | Drusen, then atrophy | New vessels, fluid, bleed |
| Risk of severe vision loss | Lower, gradual | High if untreated |
| Main treatment | AREDS2, lifestyle, monitoring | Anti-VEGF injections |
What to Expect from Treatment
- Wet AMD: Most patients stabilise; many gain some vision. Treatment is long-term — usually injections every 4–12 weeks, individualised.
- Dry AMD: AREDS2 and lifestyle slow progression. Most patients keep useful vision for many years if monitored.
- Both eyes need to be followed separately — AMD often develops in the second eye later.
Prevention & Self-Care
- Do not smoke (or stop, if you do)
- Eat green leafy vegetables, oily fish, fruits and nuts regularly
- Maintain healthy blood pressure and weight
- Wear UV-protective sunglasses outdoors
- Amsler grid weekly if you have early AMD or a family history
- Yearly dilated retinal exam after age 50; sooner if symptoms appear
- Discuss AREDS2 supplements with us if you have intermediate or advanced AMD in one eye
When to Come to Us Immediately
A new dark spot, new distortion of straight lines, a sudden drop in central vision — come the same day. Wet AMD treated within days has a far better outcome than wet AMD treated after weeks.
Frequently Asked Questions
Book an appointment for a retina evaluation at Suraj Eye Institute.
Book Appointment Now for Retina Evaluation